396 related articles for article (PubMed ID: 15857936)
1. Enhancement of antigen acquisition by dendritic cells and MHC class II-restricted epitope presentation to CD4+ T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection.
Mwangi W; Brown WC; Splitter GA; Zhuang Y; Kegerreis K; Palmer GH
J Leukoc Biol; 2005 Aug; 78(2):401-11. PubMed ID: 15857936
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccine construct incorporating intercellular trafficking and intracellular targeting motifs effectively primes and induces memory B- and T-cell responses in outbred animals.
Mwangi W; Brown WC; Splitter GA; Davies CJ; Howard CJ; Hope JC; Aida Y; Zhuang Y; Hunter BJ; Palmer GH
Clin Vaccine Immunol; 2007 Mar; 14(3):304-11. PubMed ID: 17215335
[TBL] [Abstract][Full Text] [Related]
3. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals.
Njongmeta LM; Bray J; Davies CJ; Davis WC; Howard CJ; Hope JC; Palmer GH; Brown WC; Mwangi W
Vaccine; 2012 Feb; 30(9):1624-35. PubMed ID: 22240344
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
Hung CF; Hsu KF; Cheng WF; Chai CY; He L; Ling M; Wu TC
Cancer Res; 2001 Feb; 61(3):1080-8. PubMed ID: 11221836
[TBL] [Abstract][Full Text] [Related]
5. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals.
Mwangi W; Brown WC; Lewin HA; Howard CJ; Hope JC; Baszler TV; Caplazi P; Abbott J; Palmer GH
J Immunol; 2002 Oct; 169(7):3837-46. PubMed ID: 12244180
[TBL] [Abstract][Full Text] [Related]
6. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
Herrera OB; Brett S; Lechler RI
Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
8. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
[TBL] [Abstract][Full Text] [Related]
10. A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae.
Pinchuk I; Starcher BC; Livingston B; Tvninnereim A; Wu S; Appella E; Sidney J; Sette A; Wizel B
J Immunol; 2005 May; 174(9):5729-39. PubMed ID: 15843575
[TBL] [Abstract][Full Text] [Related]
11. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of Anaplasma marginale major surface protein (MSP)1a and MSP2 epitope-specific CD4+ T lymphocytes using bovine DRB3*1101 and DRB3*1201 tetramers.
Norimine J; Han S; Brown WC
Immunogenetics; 2006 Sep; 58(9):726-39. PubMed ID: 16924490
[TBL] [Abstract][Full Text] [Related]
13. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
14. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
15. A genetic immunization adjuvant system based on BVP22-antigen fusion.
Oliveira SC; Harms JS; Afonso RR; Splitter GA
Hum Gene Ther; 2001 Jul; 12(10):1353-9. PubMed ID: 11440628
[TBL] [Abstract][Full Text] [Related]
16. Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.
Hung CF; Cheng WF; Chai CY; Hsu KF; He L; Ling M; Wu TC
J Immunol; 2001 May; 166(9):5733-40. PubMed ID: 11313416
[TBL] [Abstract][Full Text] [Related]
17. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation.
Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J
Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity.
Kim TW; Hung CF; Kim JW; Juang J; Chen PJ; He L; Boyd DA; Wu TC
Hum Gene Ther; 2004 Feb; 15(2):167-77. PubMed ID: 14975189
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of immunization against cancer using chimeric antigens.
Engelhorn ME; Guevara-Patiño JA; Merghoub T; Liu C; Ferrone CR; Rizzuto GA; Cymerman DH; Posnett DN; Houghton AN; Wolchok JD
Mol Ther; 2008 Apr; 16(4):773-81. PubMed ID: 18301399
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
